D.E. Shaw & Co’s Inhibrx INBX Stock Holding History
Bought
Maintained
Sold
Other funds holding INBX
D.E. Shaw & Co's INBX Position: Q3 2026 in Review
D.E. Shaw & Co reduced its Inhibrx (INBX) stake by 16% in Q3 2026, selling an estimated $348K and leaving 18,833 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3293.
D.E. Shaw & Co first reported a position in INBX in Q3 2025 and has held it in 5 quarters since. The position peaked at $9.6M in Q4 2025. 173 funds tracked by Wall St. Rank hold INBX as of Q3 2026.
- D.E. Shaw & Co held 18,833 shares of Inhibrx worth $1.88M as of Q3 2026.
- D.E. Shaw & Co sold 3,489 Inhibrx shares in Q3 2026, an estimated $348K.
- Inhibrx made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q3 2026, its #3293 holding.
- D.E. Shaw & Co first reported a position in Inhibrx in Q3 2025 and has held it in 5 quarters since.
- D.E. Shaw & Co's Inhibrx position peaked at $9.6M in Q4 2025.
- 173 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.